Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 1
2001 1
2002 3
2003 6
2004 2
2005 6
2006 7
2007 3
2008 5
2009 1
2010 2
2011 5
2012 3
2013 5
2014 8
2015 11
2016 15
2017 4
2018 9
2019 10
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32616537

102 results
Results by year
Filters applied: . Clear all
Page 1
Amphiregulin Aggravates Glomerulonephritis via Recruitment and Activation of Myeloid Cells.
Melderis S, Hagenstein J, Warkotsch MT, Dang J, Herrnstadt GR, Niehus CB, Neumann K, Panzer U, Berasain C, Avila MA, Tharaux PL, Tiegs G, Steinmetz OM. Melderis S, et al. J Am Soc Nephrol. 2020 Sep;31(9):1996-2012. doi: 10.1681/ASN.2019111215. Epub 2020 Jul 2. J Am Soc Nephrol. 2020. PMID: 32616537
IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation.
Krohn S, Nies JF, Kapffer S, Schmidt T, Riedel JH, Kaffke A, Peters A, Borchers A, Steinmetz OM, Krebs CF, Turner JE, Brix SR, Paust HJ, Stahl RAK, Panzer U. Krohn S, et al. J Am Soc Nephrol. 2018 Apr;29(4):1210-1222. doi: 10.1681/ASN.2017090949. Epub 2018 Feb 26. J Am Soc Nephrol. 2018. PMID: 29483158 Free PMC article.
OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.
Odobasic D, Ruth AJ, Oudin V, Kitching AR, Holdsworth SR. Odobasic D, et al. Nephrol Dial Transplant. 2019 Mar 1;34(3):429-441. doi: 10.1093/ndt/gfy177. Nephrol Dial Transplant. 2019. PMID: 29939347
IL-10 Receptor Signaling Empowers Regulatory T Cells to Control Th17 Responses and Protect from GN.
Diefenhardt P, Nosko A, Kluger MA, Richter JV, Wegscheid C, Kobayashi Y, Tiegs G, Huber S, Flavell RA, Stahl RAK, Steinmetz OM. Diefenhardt P, et al. J Am Soc Nephrol. 2018 Jul;29(7):1825-1837. doi: 10.1681/ASN.2017091044. Epub 2018 Jun 4. J Am Soc Nephrol. 2018. PMID: 29866800 Free PMC article.
CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.
Brix SR, Stege G, Disteldorf E, Hoxha E, Krebs C, Krohn S, Otto B, Klätschke K, Herden E, Heymann F, Lira SA, Tacke F, Wolf G, Busch M, Jabs WJ, Özcan F, Keller F, Beige J, Wagner K, Helmchen U, Noriega M, Wiech T, Panzer U, Stahl RA. Brix SR, et al. J Am Soc Nephrol. 2015 Sep;26(9):2105-17. doi: 10.1681/ASN.2014040407. Epub 2015 Mar 11. J Am Soc Nephrol. 2015. PMID: 25762060 Free PMC article.
Amphiregulin inhibits TNF-α-induced alveolar epithelial cell death through EGFR signaling pathway.
Meng C, Wang S, Wang X, Lv J, Zeng W, Chang R, Li Q, Wang X. Meng C, et al. Biomed Pharmacother. 2020 May;125:109995. doi: 10.1016/j.biopha.2020.109995. Epub 2020 Feb 27. Biomed Pharmacother. 2020. PMID: 32187954 Free article.
Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.
Raimondo S, Saieva L, Vicario E, Pucci M, Toscani D, Manno M, Raccosta S, Giuliani N, Alessandro R. Raimondo S, et al. J Hematol Oncol. 2019 Jan 8;12(1):2. doi: 10.1186/s13045-018-0689-y. J Hematol Oncol. 2019. PMID: 30621731 Free PMC article.
Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.
Gao J, Ulekleiv CH, Halstensen TS. Gao J, et al. J Exp Clin Cancer Res. 2016 Sep 26;35(1):151. doi: 10.1186/s13046-016-0422-z. J Exp Clin Cancer Res. 2016. PMID: 27669890 Free PMC article.
Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
Antonelou M, Michaëlsson E, Evans RDR, Wang CJ, Henderson SR, Walker LSK, Unwin RJ, Salama AD; RAVE-ITN Investigators. Antonelou M, et al. J Am Soc Nephrol. 2020 Feb;31(2):350-364. doi: 10.1681/ASN.2019060618. Epub 2019 Dec 26. J Am Soc Nephrol. 2020. PMID: 31879336
Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis.
Timoshanko JR, Kitching AR, Iwakura Y, Holdsworth SR, Tipping PG. Timoshanko JR, et al. Am J Pathol. 2004 Jun;164(6):1967-77. doi: 10.1016/s0002-9440(10)63757-1. Am J Pathol. 2004. PMID: 15161633 Free PMC article.
102 results
Jump to page
Feedback